Reviews Idarubicin Hydrochloride Injection


No reviews yet.

Idamycin PFS Drug Description
Idamycin PFS®
(idarubicin hydrochloride) Injection

WARNINGS

IDAMYCIN PFS Injection should be given slowly into a freely flowing intravenous
infusion. It must never be given intramuscularly or subcutaneously. Severe
local tissue necrosis can occur if there is extravasation during administration.

As is the case with other anthracyclines the use of IDAMYCIN PFS can cause
myocardial toxicity leading to congestive heart failure. Cardiac toxicity
is more common in patients who have received prior anthracyclines or who have
preexisting cardiac disease.
As is usual with antileukemic agents, severe myelosuppression occurs when
IDAMYCIN PFS is used at effective therapeutic doses.
It is recommended that IDAMYCIN PFS be administered only under the supervision
of a physician who is experienced in leukemia chemotherapy and in facilities
with laboratory and supportive resources adequate to monitor drug tolerance
and protect and maintain a patient compromised by drug toxicity. The physician
and institution must be capable of responding rapidly and completely to severe
hemorrhagic conditions and/or overwhelming infection.
Dosage should be reduced in patients with impaired hepatic or renal function.
(See DOSAGE AND ADMINISTRATION.)


DRUG DESCRIPTION



What are the possible side effects of idarubicin (Idamycin PFS)?

If you experience any of the following serious side effects from idarubicin, contact your doctor immediately:

an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
decreased bone marrow function and blood problems (extreme fatigue; easy bruising or bleeding; black, bloody or tarry stools; or fever, chills, or signs of infection);
congestive heart failure (difficulty breathing, fluid retention, chest...
Read All Potential Side Effects for Idamycin PFS »




IDAMYCIN PFS Injection contains idarubicin hydrochloride and is a sterile,
semi-synthetic, preservative-free solution (PFS) antineoplastic anthracycline
for intravenous use. Chemically, idarubicin hydrochloride is 5, 12-Naphthacenedione,
9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxyhydrochloride,
(7S-cis). The structural formula is as follows:







C26H27NO9•Hcl          
M.W 533.96
IDAMYCIN PFS is a sterile, red-orange, isotonic parenteral preservative-free
solution, available in 5 mL (5 mg), 10 mL (10 mg) and 20 mL (20 mg) single-use-only
vials.
Each mL contains Idarubicin HCL, USP 1 mg and the following inactive ingredients:
Glycerin, USP 25 mg and Water for Injection, USP q.s. Hydrochloric Acid, NF
is used to adjust the pH to a target of 3.5.Last reviewed on RxList: 10/9/2008




Idamycin PFS Drug Description
Idamycin PFS®
(idarubicin hydrochloride) Injection

WARNINGS

IDAMYCIN PFS Injection should be given slowly into a freely flowing intravenous
infusion. It must never be given intramuscularly or subcutaneously. Severe
local tissue necrosis can occur if there is extravasation during administration.

As is the case with other anthracyclines the use of IDAMYCIN PFS can cause
myocardial toxicity leading to congestive heart failure. Cardiac toxicity
is more common in patients who have received prior anthracyclines or who have
preexisting cardiac disease.
As is usual with antileukemic agents, severe myelosuppression occurs when
IDAMYCIN PFS is used at effective therapeutic doses.
It is recommended that IDAMYCIN PFS be administered only under the supervision
of a physician who is experienced in leukemia chemotherapy and in facilities
with laboratory and supportive resources adequate to monitor drug tolerance
and protect and maintain a patient compromised by drug toxicity. The physician
and institution must be capable of responding rapidly and completely to severe
hemorrhagic conditions and/or overwhelming infection.
Dosage should be reduced in patients with impaired hepatic or renal function.
(See DOSAGE AND ADMINISTRATION.)


DRUG DESCRIPTION



What are the possible side effects of idarubicin (Idamycin PFS)?

If you experience any of the following serious side effects from idarubicin, contact your doctor immediately:

an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
decreased bone marrow function and blood problems (extreme fatigue; easy bruising or bleeding; black, bloody or tarry stools; or fever, chills, or signs of infection);
congestive heart failure (difficulty breathing, fluid retention, chest...
Read All Potential Side Effects for Idamycin PFS »




IDAMYCIN PFS Injection contains idarubicin hydrochloride and is a sterile,
semi-synthetic, preservative-free solution (PFS) antineoplastic anthracycline
for intravenous use. Chemically, idarubicin hydrochloride is 5, 12-Naphthacenedione,
9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxyhydrochloride,
(7S-cis). The structural formula is as follows:







C26H27NO9•Hcl          
M.W 533.96
IDAMYCIN PFS is a sterile, red-orange, isotonic parenteral preservative-free
solution, available in 5 mL (5 mg), 10 mL (10 mg) and 20 mL (20 mg) single-use-only
vials.
Each mL contains Idarubicin HCL, USP 1 mg and the following inactive ingredients:
Glycerin, USP 25 mg and Water for Injection, USP q.s. Hydrochloric Acid, NF
is used to adjust the pH to a target of 3.5.Last reviewed on RxList: 10/9/2008




Idamycin PFS Drug Description
Idamycin PFS®
(idarubicin hydrochloride) Injection

WARNINGS

IDAMYCIN PFS Injection should be given slowly into a freely flowing intravenous
infusion. It must never be given intramuscularly or subcutaneously. Severe
local tissue necrosis can occur if there is extravasation during administration.

As is the case with other anthracyclines the use of IDAMYCIN PFS can cause
myocardial toxicity leading to congestive heart failure. Cardiac toxicity
is more common in patients who have received prior anthracyclines or who have
preexisting cardiac disease.
As is usual with antileukemic agents, severe myelosuppression occurs when
IDAMYCIN PFS is used at effective therapeutic doses.
It is recommended that IDAMYCIN PFS be administered only under the supervision
of a physician who is experienced in leukemia chemotherapy and in facilities
with laboratory and supportive resources adequate to monitor drug tolerance
and protect and maintain a patient compromised by drug toxicity. The physician
and institution must be capable of responding rapidly and completely to severe
hemorrhagic conditions and/or overwhelming infection.
Dosage should be reduced in patients with impaired hepatic or renal function.
(See DOSAGE AND ADMINISTRATION.)


DRUG DESCRIPTION



What are the possible side effects of idarubicin (Idamycin PFS)?

If you experience any of the following serious side effects from idarubicin, contact your doctor immediately:

an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
decreased bone marrow function and blood problems (extreme fatigue; easy bruising or bleeding; black, bloody or tarry stools; or fever, chills, or signs of infection);
congestive heart failure (difficulty breathing, fluid retention, chest...
Read All Potential Side Effects for Idamycin PFS »




IDAMYCIN PFS Injection contains idarubicin hydrochloride and is a sterile,
semi-synthetic, preservative-free solution (PFS) antineoplastic anthracycline
for intravenous use. Chemically, idarubicin hydrochloride is 5, 12-Naphthacenedione,
9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxyhydrochloride,
(7S-cis). The structural formula is as follows:







C26H27NO9•Hcl          
M.W 533.96
IDAMYCIN PFS is a sterile, red-orange, isotonic parenteral preservative-free
solution, available in 5 mL (5 mg), 10 mL (10 mg) and 20 mL (20 mg) single-use-only
vials.
Each mL contains Idarubicin HCL, USP 1 mg and the following inactive ingredients:
Glycerin, USP 25 mg and Water for Injection, USP q.s. Hydrochloric Acid, NF
is used to adjust the pH to a target of 3.5.Last reviewed on RxList: 10/9/2008




Idamycin PFS Drug Description
Idamycin PFS®
(idarubicin hydrochloride) Injection

WARNINGS

IDAMYCIN PFS Injection should be given slowly into a freely flowing intravenous
infusion. It must never be given intramuscularly or subcutaneously. Severe
local tissue necrosis can occur if there is extravasation during administration.

As is the case with other anthracyclines the use of IDAMYCIN PFS can cause
myocardial toxicity leading to congestive heart failure. Cardiac toxicity
is more common in patients who have received prior anthracyclines or who have
preexisting cardiac disease.
As is usual with antileukemic agents, severe myelosuppression occurs when
IDAMYCIN PFS is used at effective therapeutic doses.
It is recommended that IDAMYCIN PFS be administered only under the supervision
of a physician who is experienced in leukemia chemotherapy and in facilities
with laboratory and supportive resources adequate to monitor drug tolerance
and protect and maintain a patient compromised by drug toxicity. The physician
and institution must be capable of responding rapidly and completely to severe
hemorrhagic conditions and/or overwhelming infection.
Dosage should be reduced in patients with impaired hepatic or renal function.
(See DOSAGE AND ADMINISTRATION.)


DRUG DESCRIPTION



What are the possible side effects of idarubicin (Idamycin PFS)?

If you experience any of the following serious side effects from idarubicin, contact your doctor immediately:

an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
decreased bone marrow function and blood problems (extreme fatigue; easy bruising or bleeding; black, bloody or tarry stools; or fever, chills, or signs of infection);
congestive heart failure (difficulty breathing, fluid retention, chest...
Read All Potential Side Effects for Idamycin PFS »




IDAMYCIN PFS Injection contains idarubicin hydrochloride and is a sterile,
semi-synthetic, preservative-free solution (PFS) antineoplastic anthracycline
for intravenous use. Chemically, idarubicin hydrochloride is 5, 12-Naphthacenedione,
9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxyhydrochloride,
(7S-cis). The structural formula is as follows:







C26H27NO9•Hcl          
M.W 533.96
IDAMYCIN PFS is a sterile, red-orange, isotonic parenteral preservative-free
solution, available in 5 mL (5 mg), 10 mL (10 mg) and 20 mL (20 mg) single-use-only
vials.
Each mL contains Idarubicin HCL, USP 1 mg and the following inactive ingredients:
Glycerin, USP 25 mg and Water for Injection, USP q.s. Hydrochloric Acid, NF
is used to adjust the pH to a target of 3.5.Last reviewed on RxList: 10/9/2008




Idamycin PFS Drug Description
Idamycin PFS®
(idarubicin hydrochloride) Injection

WARNINGS

IDAMYCIN PFS Injection should be given slowly into a freely flowing intravenous
infusion. It must never be given intramuscularly or subcutaneously. Severe
local tissue necrosis can occur if there is extravasation during administration.

As is the case with other anthracyclines the use of IDAMYCIN PFS can cause
myocardial toxicity leading to congestive heart failure. Cardiac toxicity
is more common in patients who have received prior anthracyclines or who have
preexisting cardiac disease.
As is usual with antileukemic agents, severe myelosuppression occurs when
IDAMYCIN PFS is used at effective therapeutic doses.
It is recommended that IDAMYCIN PFS be administered only under the supervision
of a physician who is experienced in leukemia chemotherapy and in facilities
with laboratory and supportive resources adequate to monitor drug tolerance
and protect and maintain a patient compromised by drug toxicity. The physician
and institution must be capable of responding rapidly and completely to severe
hemorrhagic conditions and/or overwhelming infection.
Dosage should be reduced in patients with impaired hepatic or renal function.
(See DOSAGE AND ADMINISTRATION.)


DRUG DESCRIPTION



What are the possible side effects of idarubicin (Idamycin PFS)?

If you experience any of the following serious side effects from idarubicin, contact your doctor immediately:

an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
decreased bone marrow function and blood problems (extreme fatigue; easy bruising or bleeding; black, bloody or tarry stools; or fever, chills, or signs of infection);
congestive heart failure (difficulty breathing, fluid retention, chest...
Read All Potential Side Effects for Idamycin PFS »




IDAMYCIN PFS Injection contains idarubicin hydrochloride and is a sterile,
semi-synthetic, preservative-free solution (PFS) antineoplastic anthracycline
for intravenous use. Chemically, idarubicin hydrochloride is 5, 12-Naphthacenedione,
9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxyhydrochloride,
(7S-cis). The structural formula is as follows:







C26H27NO9•Hcl          
M.W 533.96
IDAMYCIN PFS is a sterile, red-orange, isotonic parenteral preservative-free
solution, available in 5 mL (5 mg), 10 mL (10 mg) and 20 mL (20 mg) single-use-only
vials.
Each mL contains Idarubicin HCL, USP 1 mg and the following inactive ingredients:
Glycerin, USP 25 mg and Water for Injection, USP q.s. Hydrochloric Acid, NF
is used to adjust the pH to a target of 3.5.Last reviewed on RxList: 10/9/2008





Other reviews about Idarubicin Hydrochloride Injection on wordpress

They have curly hair, an
  by zgmntciptjol
Half an hour afterwards Shorty appeared at the Elkhorn. Faith, she cried, Id forgotten the little green shoes! And because of my feeling, all the events that followed […]


Captain Han Pritcher was ordere
  by oshlsoopizvgkaq
Come on down to breakfast when youre dressed, Lloyd said. And one day came the first white man. Burke accepted the lame excuse without question. Malaysia diet plans Plans […]



Other reviews about Idarubicin Hydrochloride Injection on web:

Idarubicin Hydrochloride Injection. 18 August 2010. Products Affected - Description Bulletin


Idarubicin Hydrochloride Solution for injection To return to the main entry click here . What is this medicine? IDARUBICIN (eye da RUE bi sin) is a Idarubicin Hydrochloride Solution for injection: Information from ...


1 Idarubicin Hydrochloride Injection Rx only FOR INTRAVENOUS USE ONLY WARNINGS 1. Idarubicin Hydrochloride Injection should be given slowly into a freely flowing intravenous infusion. Idarubicin Hydrochloride Injection


1 Idamycin ® idarubicin hydrochloride for injection, USP Rx only FOR INTRAVENOUS USE ONLY WARNINGS 1. IDAMYCIN (idarubicin hydrochloride for injection, USP) should be given ... Idamycin® idarubicin hydrochloride for injection, USP


Learn about the prescription medication Idamycin PFS (Idarubicin Hydrochloride Injection), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling. Idamycin PFS (Idarubicin Hydrochloride Injection) Drug Information ...


IDARUBICIN HYDROCHLORIDE INJECTION. Product Insert: DIN: 02337584: Product Code: C109420: Description: 1 mg/mL: Size / Format Pharmaceutical Partners of Canada


Care in the administration of Idarubicin hydrochloride injection will reduce the chance of perivenous infiltration. It may also decrease the chance of local reactions such as ... Idarubicin Official FDA information, side effects and uses.


Idarubicin Hydrochloride Solution for injection What is this medicine? IDARUBICIN (eye da RUE bi sin) is a chemotherapy drug. This medicine is used to treat acute myeloid ... Idarubicin


»Idarubicin Hydrochloride for Injection is a sterile mixture of Idarubicin Hydrochloride and Lactose.It contains not less than 90.0percent and not more than 110.0percent of the ... Idarubicin Hydrochloride for Injection, chemical structure ...


Idarubicin Hydrochloride Injection : Ifosfamide for Injection, USP : Ifosfamide Injection : Indomethacin for Injection : Irinotecan Hydrochloride Injection APP - Products - Product Detail





Featured Reviews

Reviews Alclometasone Dipropionate

Aclovate Drug Description ACLOVATE® (alclometasone dipropionate) Cream, 0.05% ACLOVATE® (alclometasone dipropionate) Ointment, 0.05% For Dermatologic Use Only— Not for Ophthalmic Use. DRUG DESCRIPTION What are the possible...
Read More  |  Review This
Reviews Indinavir Sulfate

Crixivan Drug Description CRIXIVAN® (indinavir sulfate) Capsules DRUG DESCRIPTION What are the possible side effects of indinavir (Crixivan)? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Reviews Albuterol Sulfate Inhalation Solution

Albuterol Sulfate Drug Description Albuterol Sulfate Inhalation Solution 0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL) (*Potency expressed as albuterol, equivalent to 1.5 mg and 0.75 mg albuterol sulfate) DRUG DESCRIPTION What...
Read More  |  Review This
Reviews Desogestrel Ethinyl Estradiol Tablets

Cyclessa Drug Description Cyclessa® (desogestrel/ethinyl estradiol tablets) Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases. DRUG DESCRIPTION What...
Read More  |  Review This
Reviews Cefuroxime Axetil

Ceftin Drug Description CEFTIN® Tablets (cefuroxime axetil) Tablets CEFTIN® for Oral Suspension (cefuroxime axetil) Powder for Oral Suspension To reduce the development of drug-resistant bacteria and maintain the effectiveness...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....